Funding allows researchers to uncover the secrets of COVID-19 immunity

Federal funding will help a team of researchers determine how long immunity lasts in people who’ve recovered from COVID-19, critical information as the world waits for a vaccine. The Commonwealth Government’s Medical Research Future Fund (MRFF) has granted almost a million dollars to the two year project, run by The University of Queensland, QIMR Berghofer…

Read More

UQ tech could offer ‘faster, cheaper and mobile’ COVID-19 diagnosis

Technology that helps to quickly extract and analyse genetic material could be used for cheap, accurate and mobile COVID-19 testing, including at airports and remote testing centres. ‘Dipstick’ technology, developed by the University of Queensland’s Professor Jimmy Botella and Dr Michael Mason, allows genetic material to be extracted in as little as 30 seconds, with…

Read More

Landmark deal for UQ-Trinity inflammation startup

A startup company developing treatments for inflammatory diseases based on a research partnership between The University of Queensland and Trinity College Dublin (TCD) has been acquired in a landmark deal – one of the largest in Australian and Irish biotech history. Inflazome has been acquired by Roche for an upfront cash payment of €380 million (about $A617 million), plus additional payments based…

Read More

CSL signs agreement with Australian Government for UQ vaccine supply

Global biotech company CSL Limited will supply the Australian Government with 51 million doses of The University of Queensland’s COVID-19 vaccine candidate if it proves successful, under a heads of agreement announced today. CSL expects the first tranche of doses to be available by mid-2021, with additional doses following in late 2021 and early 2022,…

Read More

Discovery promising for millions at risk from antibiotic resistance

There is new hope for approximately 700,000 people who die each year from antibiotic resistant infections, with University of Queensland researchers discovering how bacteria share antibiotic-resistance genes. UQ’s Professor Mark Schembri said antibiotic resistant bacteria, in particular emerging ‘superbugs’, could lead to around 10 million deaths globally by 2050. “The diminishing pool of effective antibiotics makes these infections a…

Read More

UQ welcomes back Professor Deborah Terry

The university sector will be vital in the state’s recovery from COVID-19, according to incoming University of Queensland Vice-Chancellor, Professor Deborah Terry. Professor Terry returns to UQ on Monday (3 August) after more than six years serving as Vice-Chancellor and President of Curtin University in Western Australia. Professor Terry said UQ was an incredibly strong…

Read More